WGS is trading at $66.06 (4.1% down) following fresh attention on securities fraud class action lawsuits tied to its Fabric Genomics acquisition and previous earnings disclosures.
- The legal scrutiny involves alleged misstatements in Q1 2026 reports, a situation that previously triggered a ~49% collapse in the stock price.
- Shares continue to face pressure from recent guidance disappointments and missed Q1 estimates, creating a persistent sentiment overhang.
- Multiple law firms are currently highlighting upcoming investor deadlines, further impacting market confidence today.